跳至主要内容
临床试验/NCT02158598
NCT02158598已完成4 期

Comparison of Changes in Serum 25(OH)D Concentrations Following Vitamin D Supplementation With Chewable Tablets Versus Pills

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
38
试验地点
1
主要终点
Change in Serum 25(OH)D concentration

研究概览

简要总结

This is a 6-month cross-over trial of vitamin D supplementation in 38 healthy men and women aged 18 years and older. The primary aim is to compare the change in serum 25(OH)D concentration following vitamin D supplementation with chewable tablets versus pills. Secondary aims are to evaluate satisfaction and adherence to the vitamin D chewable tablet supplement. Questionnaires on physical activity, sunlight exposure and dairy product consumption will be administered to adjust for confounding factors. A questionnaire will be administered to assess satisfaction and pill count to evaluate adherence to treatment. This research intends to test the hypothesis that the vitamin D chewable tablet supplement is as effective as a traditional vitamin D pill supplement to increase serum 25(OH)D concentrations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Caucasian men and women;
  • Aged 18 years and older;
  • Having a serum 25(OH)D concentration of 75 nmol/L or less.

排除标准

  • Regular consumption of a supplement containing > 400 IU/d of vitamin D over the last 2 months;
  • Intestinal malabsorption;
  • Cirrhosis;
  • Renal insufficiency (creatinine clearance <60 ml/min);
  • Hypercalcemia;
  • Pregnancy;
  • Breastfeeding;
  • Inability to provide informed consent.

研究组 & 干预措施

Vitamin D chewable tablet supplementation

Experimental

A chewable vitamin D tablet containing 1000 IU to be taken once a day for 2 months.

干预措施: Vitamin D chewable tablet supplementation (Drug)

Vitamin D pill supplementation

Experimental

A vitamin D pill containing 1000 IU to be taken once a day for 2 months.

干预措施: Vitamin D pill supplementation (Drug)

结局指标

主要结局

Change in Serum 25(OH)D concentration

时间窗: 0 and 2 months, 4 and 6 months

次要结局

  • Satisfaction with the vitamin D chewable tablets and pills.(0 and 2 months, 4 and 6 months)
  • Adherence to the vitamin D chewable tablets and pills.(0 and 2 months, 4 and 6 months)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudia Gagnon

MD

CHU de Quebec-Universite Laval

研究点 (1)

Loading locations...

相似试验